Rapid Micro Biosystems (NASDAQ:RPID) Cut to Sell at Wall Street Zen

Wall Street Zen cut shares of Rapid Micro Biosystems (NASDAQ:RPID) from a hold rating to a sell rating in a report issued on Saturday.

Separately, Weiss Ratings restated a “sell (d-)” rating on shares of Rapid Micro Biosystems in a research report on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, one has given a Buy rating and one has issued a Sell rating to the stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and a consensus target price of $8.00.

Rapid Micro Biosystems Stock Up 21.2%

NASDAQ:RPID opened at $4.18 on Friday. The firm has a 50-day simple moving average of $3.64 and a two-hundred day simple moving average of $3.32. The firm has a market cap of $185.26 million, a P/E ratio of -4.14 and a beta of 1.36. Rapid Micro Biosystems has a fifty-two week low of $1.10 and a fifty-two week high of $4.50. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.95 and a current ratio of 4.23.

Rapid Micro Biosystems (NASDAQ:RPID) last announced its quarterly earnings results on Friday, November 7th. The company reported ($0.26) earnings per share (EPS) for the quarter, meeting analysts’ consensus estimates of ($0.26). Rapid Micro Biosystems had a negative return on equity of 73.90% and a negative net margin of 145.11%.The firm had revenue of $7.84 million for the quarter, compared to the consensus estimate of $7.60 million. Analysts predict that Rapid Micro Biosystems will post -1.1 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Rapid Micro Biosystems

Large investors have recently added to or reduced their stakes in the company. Evernest Financial Advisors LLC boosted its position in Rapid Micro Biosystems by 355.1% during the 3rd quarter. Evernest Financial Advisors LLC now owns 200,234 shares of the company’s stock valued at $669,000 after acquiring an additional 156,234 shares in the last quarter. Vanguard Group Inc. boosted its stake in Rapid Micro Biosystems by 6.7% during the 3rd quarter. Vanguard Group Inc. now owns 965,018 shares of the company’s stock valued at $3,223,000 after purchasing an additional 60,655 shares during the last quarter. XTX Topco Ltd purchased a new position in shares of Rapid Micro Biosystems in the second quarter worth $144,000. Dimensional Fund Advisors LP increased its holdings in Rapid Micro Biosystems by 37.8% in the 3rd quarter. Dimensional Fund Advisors LP now owns 55,642 shares of the company’s stock worth $186,000 after buying an additional 15,255 shares in the last quarter. Finally, Hudson Bay Capital Management LP purchased a new stake in shares of Rapid Micro Biosystems during the 3rd quarter valued at about $38,000. Hedge funds and other institutional investors own 52.60% of the company’s stock.

Rapid Micro Biosystems Company Profile

Rapid Micro Biosystems (NASDAQ: RPID) develops and commercializes automated microbial detection and contamination control solutions for the life sciences industry. Its flagship offering, the Growth Direct® System, leverages digital imaging and proprietary growth indicator plates to identify and count microorganisms more rapidly than traditional culture-based methods. The company’s technology platform is designed to streamline quality control workflows in pharmaceutical, biotechnology and vaccine manufacturing settings, helping clients reduce release times and improve operational efficiency.

In addition to the Growth Direct® System, Rapid Micro Biosystems offers an integrated suite of software and consumables that support automated data capture, analysis and reporting.